A Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Pelacarsen (ISIS 681257) in Healthy Japanese Participants
Clinical trial NCT05337878 · COMPLETED
Trial details
- NCT number
- NCT05337878
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-15
- Primary completion
- 2019-12-18
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.